4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-23-014993
Options or other derivatives
- Chief Medical Officer acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Larimar Therapeutics, Inc. Filed Acc 0001062993-23-014993
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…